2018
DOI: 10.2144/000114625
|View full text |Cite
|
Sign up to set email alerts
|

Part II: Breakthroughs in Tumor-Seeking Bacteria

Abstract: Newly engineered bacterial strains propel an immune-mediated cancer therapy toward clinical applications. Hannah Martin Lawrenz reports on the latest developments.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2019
2019
2019
2019

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 3 publications
0
1
0
Order By: Relevance
“…A number of recent reviews have illustrated this role of Salmonella quite elaborately (Wang et al . ; Hernandez‐Luna and Luria‐Perez ; Lawrenz ). It has been hypothesised that the release of various pro‐inflammatory factors of bacterial pathogen‐associated molecular patterns triggers the antitumour activity of S .…”
Section: Nontyphoidal Salmonella: a Model For Cancer Therapymentioning
confidence: 99%
“…A number of recent reviews have illustrated this role of Salmonella quite elaborately (Wang et al . ; Hernandez‐Luna and Luria‐Perez ; Lawrenz ). It has been hypothesised that the release of various pro‐inflammatory factors of bacterial pathogen‐associated molecular patterns triggers the antitumour activity of S .…”
Section: Nontyphoidal Salmonella: a Model For Cancer Therapymentioning
confidence: 99%